GlaxoSmithKline RSV vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GlaxoSmithKline RSV vaccine, covering 2022-04-07 to 2022-04-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Safety, Reactogenicity and Immune Response of the Repeat Vaccination Against RSV When Given to Female Participants of 18-49 Years of Age During Their Subsequent Uncomplicated Pregnancy [Phase 3]